Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Swen Hesse

Showing results (81-90 of 117) with videos related to

Pageof 12
Sort By:
Frontiers in Pharmacology|July 3, 2019
<i>In vitro</i> and <i>in vivo</i> Human Metabolism of (<i>S</i>)-[<sup>18</sup>F]Fluspidine - A Radioligand for Imaging σ<sub>1</sub> Receptors With Positron Emission Tomography (PET)Friedrich-Alexander Ludwig, Steffen Fischer, Richard Houska, et al.
Journal of Alzheimer'S Disease : JAD|November 8, 2018
Dual Time-Point [18F]Florbetaben PET Delivers Dual Biomarker Information in Mild Cognitive Impairment and Alzheimer's DiseaseLisa Florek, Solveig Tiepolt, Matthias L Schroeter, et al.
Journal of Cachexia, Sarcopenia and Muscle|August 27, 2024
Detection of cancer-associated cachexia in lung cancer patients using whole-body [<sup>18</sup>F]FDG-PET/CT imaging: A multi-centre studyDaria Ferrara, Elisabetta M Abenavoli, Thomas Beyer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 22, 2012
Imaging of the brain serotonin transporters (SERT) with 18F-labelled fluoromethyl-McN5652 and PET in humansSwen Hesse, Peter Brust, Peter Mäding, et al.
EJNMMI Research|January 26, 2017
The impact of reconstruction and scanner characterisation on the diagnostic capability of a normal database for [<sup>123</sup>I]FP-CIT SPECT imagingJohn C Dickson, Livia Tossici-Bolt, Terez Sera, et al.
Stress (Amsterdam, Netherlands)|October 30, 2018
Central noradrenaline transporter availability is linked with HPA axis responsiveness and copeptin in human obesity and non-obese controlsChristian Schinke, Swen Hesse, Michael Rullmann, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 7, 2011
Individualized quantification of brain β-amyloid burden: results of a proof of mechanism phase 0 florbetaben PET trial in patients with Alzheimer's disease and healthy controlsHenryk Barthel, Julia Luthardt, Georg Becker, et al.
Nuclear Medicine and Biology|April 29, 2014
Evaluation of metabolism, plasma protein binding and other biological parameters after administration of (-)-[(18)F]Flubatine in humansMarianne Patt, Georg A Becker, Udo Grossmann, et al.
EJNMMI Physics|January 29, 2017
[<sup>123</sup>I]FP-CIT ENC-DAT normal database: the impact of the reconstruction and quantification methodsLivia Tossici-Bolt, John C Dickson, Terez Sera, et al.
Biological Psychiatry|March 30, 2023
Increase in Serotonin Transporter Binding in Patients With Premenstrual Dysphoric Disorder Across the Menstrual Cycle: A Case-Control Longitudinal Neuroreceptor Ligand Positron Emission Tomography Imaging StudyJulia Sacher, Rachel G Zsido, Claudia Barth, et al.
Pageof 12

Showing results (81-90 of 117) with videos related to

Sort By:
Pageof 12
Frontiers in Pharmacology|July 3, 2019
<i>In vitro</i> and <i>in vivo</i> Human Metabolism of (<i>S</i>)-[<sup>18</sup>F]Fluspidine - A Radioligand for Imaging σ<sub>1</sub> Receptors With Positron Emission Tomography (PET)Friedrich-Alexander Ludwig, Steffen Fischer, Richard Houska, et al.
Journal of Alzheimer'S Disease : JAD|November 8, 2018
Dual Time-Point [18F]Florbetaben PET Delivers Dual Biomarker Information in Mild Cognitive Impairment and Alzheimer's DiseaseLisa Florek, Solveig Tiepolt, Matthias L Schroeter, et al.
Journal of Cachexia, Sarcopenia and Muscle|August 27, 2024
Detection of cancer-associated cachexia in lung cancer patients using whole-body [<sup>18</sup>F]FDG-PET/CT imaging: A multi-centre studyDaria Ferrara, Elisabetta M Abenavoli, Thomas Beyer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 22, 2012
Imaging of the brain serotonin transporters (SERT) with 18F-labelled fluoromethyl-McN5652 and PET in humansSwen Hesse, Peter Brust, Peter Mäding, et al.
EJNMMI Research|January 26, 2017
The impact of reconstruction and scanner characterisation on the diagnostic capability of a normal database for [<sup>123</sup>I]FP-CIT SPECT imagingJohn C Dickson, Livia Tossici-Bolt, Terez Sera, et al.
Stress (Amsterdam, Netherlands)|October 30, 2018
Central noradrenaline transporter availability is linked with HPA axis responsiveness and copeptin in human obesity and non-obese controlsChristian Schinke, Swen Hesse, Michael Rullmann, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 7, 2011
Individualized quantification of brain β-amyloid burden: results of a proof of mechanism phase 0 florbetaben PET trial in patients with Alzheimer's disease and healthy controlsHenryk Barthel, Julia Luthardt, Georg Becker, et al.
Nuclear Medicine and Biology|April 29, 2014
Evaluation of metabolism, plasma protein binding and other biological parameters after administration of (-)-[(18)F]Flubatine in humansMarianne Patt, Georg A Becker, Udo Grossmann, et al.
EJNMMI Physics|January 29, 2017
[<sup>123</sup>I]FP-CIT ENC-DAT normal database: the impact of the reconstruction and quantification methodsLivia Tossici-Bolt, John C Dickson, Terez Sera, et al.
Biological Psychiatry|March 30, 2023
Increase in Serotonin Transporter Binding in Patients With Premenstrual Dysphoric Disorder Across the Menstrual Cycle: A Case-Control Longitudinal Neuroreceptor Ligand Positron Emission Tomography Imaging StudyJulia Sacher, Rachel G Zsido, Claudia Barth, et al.
Pageof 12